Karachalios Dimitrios, Guthoff Rudolf F, Kundt Günther, Thiesen Frank, Kopp Franziska, Siewert Stefan, Koschmieder Anita, Jünemann Anselm, Stahnke Thomas
Klinik und Poliklinik für Augenheilkunde, Universitätsmedizin Rostock.
Institut für Biostatistik und Informatik in Medizin und Alternsforschung, Universitätsmedizin Rostock.
Klin Monbl Augenheilkd. 2020 Sep;237(9):1117-1123. doi: 10.1055/a-1214-3875. Epub 2020 Sep 23.
Glaucoma is one of the most common causes of blindness worldwide. The only evidence-based treatment to slow down the progression of glaucoma is the reduction of intraocular pressure (IOP) using local medication or through surgery. During the last years, a large number of microinvasive glaucoma surgery techniques (MIGS) has been developed, in order to reduce the IOP in glaucoma patients safely and effectively. Until now, efficacy of MIGS has been assessed mainly according to the postoperative IOP and the number of medications used. Results from long-term studies are rare or not available in the majority of the cases. In order to better evaluate the functionality of MIGS, a new examination method has been developed with the help of a new oculopressor device. In this study the efficacy of different MIGS techniques will be examined using the new oculopressor.
MATERIAL/METHODS: At first, glaucoma patients that had previously received a MIGS surgery (iStent inject, XEN Stent, ELT) were examined with the new oculopression test. Their results were compared with those of non-operated patients and healthy individuals. Overall, 38 healthy subjects (group 1), 10 non-operated patients (group 2), 19 patients after iStent inject implantation (group 3), 14 patients after XEN Stent implantation (group 4) and 5 patients after ELT (group 5) were examined. The new examination measures the IOP-reduction that occurs after oculopression and can be seen as an indirect measurement of the outflow facility of the eye.
The IOP-reduction after oculopression differed among the study groups. Non-operated patients showed a significantly lower IOP-reduction compared to healthy individuals. Patients after iStent inject and XEN stent implantation showed a larger reduction of IOP after oculopression in relation to non-operated patients and their results approximated those of healthy individuals. These patients needed fewer medications postoperatively in relation to non-operated patients. Patients after ELT showed postoperatively a smaller reduction of IOP after oculopression compared to iStent inject and XEN stent patients.
MIGS can increase the outflow facility of the eye in patients with glaucoma. Though ELT had the lowest impact on the aqueous outflow among the studied procedures in this study. The new test can help in the evaluation of current and further development of new MIGS in the future.
青光眼是全球最常见的致盲原因之一。唯一经循证医学验证可减缓青光眼病情发展的治疗方法是使用局部药物或通过手术降低眼压(IOP)。在过去几年中,已开发出大量微创青光眼手术技术(MIGS),以便安全有效地降低青光眼患者的眼压。到目前为止,MIGS的疗效主要根据术后眼压和所用药物数量进行评估。在大多数情况下,长期研究的结果很少或无法获得。为了更好地评估MIGS的功能,借助一种新型眼压计开发了一种新的检查方法。在本研究中,将使用新型眼压计检查不同MIGS技术的疗效。
材料/方法:首先,对先前接受过MIGS手术(iStent注射、XEN支架、ELT)的青光眼患者进行新型眼压测试。将他们的结果与未手术患者和健康个体的结果进行比较。总共检查了38名健康受试者(第1组)、10名未手术患者(第2组)、19名接受iStent注射植入术后的患者(第3组)、14名接受XEN支架植入术后的患者(第4组)和5名接受ELT术后的患者(第5组)。这项新检查测量眼压后眼压的降低情况,可视为对眼睛房水流出功能的间接测量。
眼压降低情况在各研究组之间存在差异。与健康个体相比,未手术患者的眼压降低明显更低。接受iStent注射和XEN支架植入术后的患者在眼压后眼压降低幅度相对于未手术患者更大,其结果接近健康个体。与未手术患者相比这些患者术后所需药物更少。与接受iStent注射和XEN支架植入术后的患者相比,接受ELT术后的患者在眼压后眼压降低幅度较小。
MIGS可增加青光眼患者眼睛的房水流出功能。尽管在本研究中,ELT在所研究的手术中对房水流出的影响最小。这项新测试有助于评估当前的MIGS以及未来新型MIGS的进一步发展。